2016 brought us a near-constant stream of news about SGLT-2 Inhibitors, from their role in combination therapies to their cardiovascular benefits. Here are the ten SGLT-2 items that most engaged you this year.

January:

February:

April:

May:

June:

July:

September: 

October: